Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
2018 could prove to be very interesting indeed.
We shall see :)
HHSE Board of Directors approves Uplisting / Registration Costs
This will be the catalyst to finally make HHSE into a money maker.
With NO DILUTION the price should move up rather quickly once this is achieved.
Two Major Titles In Theatrical Releases.
BATTLECREEK
DAISY WINTERS
The VOD revenue should be quite handsome from these.
[color=red][/color]Great info! Especially the NO DILUTION
Stay tuned :)
SPOKE WITH MARSHA AT T.A.. SHARE STRUCTURE UNCHANGED. 800m, 799m, 100m restr.
Very interesting thanks!!
GREAT! Thanks Spec for keeping the board updated with the FACTS
Interesting DD indeed Thanks Niko for connecting the dots!
Dated: October 14, 2016 NO DILUTION COMMITMENT TO SHAREHOLDERS; which has been HONORED for ~20 MONTHS & is EXPECTED to CONTINUE:
Quote:HHSE has not issued any new shares since August, 2015, and there is no activity or planning underway to issue any new shares. The Company has also not entered into any "convertible notes" since 2014, that require stock (instead of cash payments) for retirement, thus alleviating pressures of equity conversions. ... Accordingly, there will not be a supply of "cheap shares" flooding the market, as some day traders have predicted incorrectly for the past two+ years. It's all forward progress for the PPS from here, and with outstanding strength and momentum from the Company's current activities, we are incredibly bullish on the future.
No new shares since Aug 2015 if I am not mistaken.
I am pretty sure that is more than 1 year & going on 2
"Company has no plans to issue shares' and have not.
Absolutely not, do some DD as to the explanation.
Kim/TA has the AS listed as 800m and the RS at 100m until she declares a change then there is no change.
AS listed as 800m and the restricted shares
at 100 Thanks for calling the T/A NO DILUTION going on 2 years?
Multi-Million Dollar (Non-Toxic) FINANCINGGreat to hear this!
Increasing volume says something is up..like it!
Nice Close!! Go HHSE!!
$1,000,000 Month of January New Release Sales & Shipments that is some serious sales
GREAT PROGRESS Relocated HHSE From Warehouse Facilities Into Executive Offices Suite..more affluent business location.
HAPPENING NOW activities to get the stock shares fully registered in final process!
Fabricated gloom & doom. A whole lot of action going on if one chooses to do some actual DD.
Increasing AS (for the purpose of complying with the stated reasons for the F10)is not dilution....raising the OS is...OS hasn't been raised since Aug 2015, I believe is correct date.
Annual Registration Fee:Wyoming SOS HHSE Tax Standing: Paid & Good
NICE!!#241730 Sticky Note HHSE/Medallion Will Post $1,000,000 Month In January, 2017
More HHSE housekeeping[Wyoming SOS HHSE Tax Standing: Paid & Good ..2017..GO HHSE
Thanks for keeping the board updated Speck!
Item 11 A1-A6 – Supplemental Disclosures.
i). The Company has completed the written and disclosure portions of a Form 10-12(g) Registration Statement, which was previously planned for filing with the Securities and Exchange Commission on or Jan. 15, 2016, subject to the completion of outside audits by a PCAOB licensed auditing firm. The Company has since engaged a qualifying auditing firm and participated in extensive interviews and reviews of filings, reports and back-up materials. As disclosed to shareholders on the HHSE Company blog site on January 30, 2016, the new auditors have made several determinations of material deficiencies in the financials for the Company, specifically, 1). The value of the Film Library relative to all other assets (and the issues of the five-year-aging of the prior Film Library Valuation report, the changing marketplace for physical video sales as compared to the growing market for digital streaming, and the significant exclusions of key titles from the prior Film Library) and 2). The need for Internal Controls and Compliance Documentation that would conform to standards prescribed under Sarbanes-Oxley Act 404. While technically not “advising” the Company on how to conduct internal controls or instructing the Company to conduct a more thorough and current Film Library Valuation Study, the new auditors did clarify that not addressing or rectifying these issues would result in significant comments by the auditors to the Form 10-12(g) audit portion, and this could result in commentary and non-compliance following S.E.C. review of the registration filing. Having the Company’s largest balance sheet asset reviewed under more recent valuation, and having the Company conform to widely accepted Internal Controls Procedures, would be a requirement for the auditors, unless the Company was willing to proceed with significant auditor’s footnote commentary on these issues. Rather than risk having another obstacle impact the S.E.C. acceptance of the Company’s registration, management has taken the steps to conform to these higher disclosure and operational standards. Company anticipates that the updated Form 10-12(g) Registration Filing, including 2-years of full-year audits and a revised and updated Film Library Valuation Report will be submitted to the S.E.C. in the near-term future, subject to the completion of the new Film Library Valuation (it should be noted that Company is seeking to obtain a lowered valuation than the initial figure determined by the new Library Evaluators, which contains sales forecasts for titles greater than Company Management’s estimates. It is Company’s position that a Library Valuation that is significantly higher than forecasts based on Company’s existing, internal self-distribution apparatus, could elevate shareholder expectations higher than management’s more conservative forecasts. While the higher sales values provided by the first Library Valuation report have as a premise the assumption that HHSE will align itself with one of the Major Studios in the coming year, there can be no assurance that such a deal will occur, and as such, management feels that the current Film Library Valuation should reflect existing distribution channels and revenues, and conform closer to management’s estimated current value of $28-mm. A review of sales activities at the Cannes Film Festival and Marche du Film and other relevant agenda items affecting the Company’s Film Library Valuation have occurred over the summer (2016) and the Company feels confident of having reached a consensus with the valuators on the current and anticipated value of each title, by media income stream.
Director Dean C. Jones names HHSE in yet ANOTHER film title:
Christopher Waltz (Inglourious Basterds, Django Unchained) and Patricia Arquette (Boyhood, True Romance) are currently being sought after for lead roles in Dean C. Jones upcoming film "Asylum Nights". The horror/thriller from Hannover House Pictures and Straight Jacket Productions has had a buzz around the horror circuit and we're excited to bring you this exclusive news!
Dean Jones is known for his work on:
Star Trek: The Next Generation (1987),
X-Men: First Class (2011)
Pirates of the Caribbean: Dead Man's Chest (2006).
Won 2 Primetime Emmys. Another 6 nominations
http://www.imdb.com/name/nm0427896/?ref_=nmbio_bio_nm
EXECELLENT!!! THANKS !
A lot of great tidbits in your post Niko
Quote:a). KRAFTROC – Company has contracted with Atlantic Film Studios for the production and distribution of a feature length musical film. Under the terms of the agreement, Atlantic shall be responsible for raising the production funds, estimated at $3.5-mm USD. “Kraftroc” was originally developed as a film for Michael Jackson, who was working with the principal producer, Elliott Straite (“Dr. Freeze”) prior to Jackson’s sudden and untimely death in 2009. The film chronicles the story of a team of interplanetary travelers, sent to Earth by Captain EO and challenged to spread enlightenment through music. Although visual images voice recordings of Michael Jackson are part the existing materials for KRAFTROC, there is no assurance that the trustees governing the Michael Jackson Estate will authorize such uses. Regardless, Atlantic is proceeding with the production and has already commenced principal photography. Company will be presenting a promo reel at the Cannes market and offering international rights licensors the opportunity to buy the film for their applicable territories & media.
[/quote][/quote]
SO COOL!! Great Post Thanks Speck !!Cinedigm Medallion Deal News @ Home Media Magazine
Great info coming out of Cannes thanks for the one stop updating info sharing Speckulater
AGREE COMPLETELY NIKO!! Excellent info. THANKS!!COULD A MOD STICKY THIS??
My thoughts exactly Niko
CANNES 2016 PREVIEW :MAJOR PRODUCTIONS - MID-LEVEL-TO-WIDE USA THEATRICAL RELEASES
* "MELTDOWN" - $10-mm Production, major star in lead; Terrorism-Action Theme.
* "LEGEND OF BELLE STARR" - $3.5-mm Production, major star in lead; Historic / Action / Western.
* "MOTHER GOOSE: JOURNEY TO UTOPIA" - $12-mm Production, three major stars; Family / Fantasy / Adventure.
* "DELIRIUM" - $1.5-mm Production, solid cast - Sci-Fi / Horror.
* "PATHWAY TO FREEDOM" - $1.5-mm Production, solid cast - Historic / Drama
April 30th : HHSE to commence principal photography on "Mother Goose: Journey To Utopia"), and expects to have a major announcement (and "promo reel") on display at the Company's booth at the Cannes Film Festival / Marche Du Filme in May.
CANNES MARCHE DU FILM - May 9-22 HHSE Medallion Releasing will have a significant, high-profile line-up of theatrical productions for sale to international buyers. The best forum to launch this aggressive International Licensing activity will be the Cannes Film Festival.HHSE / Medallion will have a sizable "seller's booth" at the Palais Convention Center - and will be screening completed films and "promo reels" (of films already in production) for major buyers.
"Which broker(s) charge $2.50/share to short HHSE. Please be specific. With credible links"